REPLICEL LIFE SCIENCES INC.
CIK 0001205059
Revenue (TTM)
4.12M
FY Apr 2023
Net Income (TTM)
−743.23K
+81.8% YoY
FY Apr 2023
EPS Diluted (TTM)
−0.02
+84.6% YoY
FY Apr 2023
Gross Margin
—
FY Apr 2023
Operating Margin
-33.9%
FY Apr 2023
Net Margin
-18.0%
FY Apr 2023
Free Cash Flow (TTM)
—
FY Apr 2023
Cash
413.03K
FY Apr 2023
Total Debt
—
FY Apr 2023
Shares Outstanding
65M sh
FY Apr 2023
Revenue & Net Income
EPS (Diluted)
Margins
Cash Flow
Revenue Growth (YoY)
No data available for this metric.